Absci develops next-generation protein-based drugs to unlock a better, faster path to new medicines. The company deployed this same business approach to the development of their new 80,000 sf headquarter bioscience laboratories and corporate offices. The partnership delivered 30,000 sf of biotech lab space and 30,000 sf of office, conference and gathering space in just 18 weeks to meet the needs of the firm, and are now strategically adding 20,000 sf of additional adjacent space for the continued development of life-changing medicines.
